C2N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today ...
Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...
Medical Device Network on MSN5d
C2N Diagnostics lands $10m cash injection from SamsungC2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said ...
A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a $10 million investment from several life sciences companies.
St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.
Samsung Life Science Fund made its first strategic investment of the year into C2N Diagnostics LLC, underscoring the rising potential of blood-based diagnostics in detecting and monitoring the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback